MergerLinks Header Logo

Request Deal Involvement

Servier completed the acquisition of oncology business of Agios Pharmaceuticals for $2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Goldman Sachs

financial advisors

Goldman Sachs

Morgan Stanley

financial advisors

Morgan Stanley

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

Baker McKenzie

legal advisors

Baker McKenzie

Lazard

financial advisors

Lazard

or

Principals

AGIOS PHARMACEUTICALS

vendor

AGIOS PHARMACEUTICALS

AGIOS PHARMACEUTICALS (ONCOLOGY BUSINESS)

target

AGIOS PHARMACEUTICALS (ONCOLOGY BUSINESS)

SERVIER INTERNATIONAL

bidder

SERVIER INTERNATIONAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite